nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A surrogate marker to monitor angiogenesis at last
|
Schneider, Martin |
|
2005 |
7 |
1 |
p. 3-4 2 p. |
artikel |
2 |
Context, tissue plasticity, and cancer
|
Bissell, Mina J. |
|
2005 |
7 |
1 |
p. 17-23 7 p. |
artikel |
3 |
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis
|
Fernandez-Zapico, Martin E. |
|
2005 |
7 |
1 |
p. 39-49 11 p. |
artikel |
4 |
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis
|
Shaked, Yuval |
|
2005 |
7 |
1 |
p. 101-111 11 p. |
artikel |
5 |
Mechanism-based combination telomerase inhibition therapy
|
Shay, Jerry W. |
|
2005 |
7 |
1 |
p. 1-2 2 p. |
artikel |
6 |
p27Kip1-stathmin interaction influences sarcoma cell migration and invasion
|
Baldassarre, Gustavo |
|
2005 |
7 |
1 |
p. 51-63 13 p. |
artikel |
7 |
Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis
|
Ling, Benjamin C. |
|
2005 |
7 |
1 |
p. 65-75 11 p. |
artikel |
8 |
Spying on cancer
|
Gross, Shimon |
|
2005 |
7 |
1 |
p. 5-15 11 p. |
artikel |
9 |
Stat5 tetramer formation is associated with leukemogenesis
|
Moriggl, Richard |
|
2005 |
7 |
1 |
p. 87-99 13 p. |
artikel |
10 |
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
|
Selak, Mary A. |
|
2005 |
7 |
1 |
p. 77-85 9 p. |
artikel |
11 |
Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics
|
Seimiya, Hiroyuki |
|
2005 |
7 |
1 |
p. 25-37 13 p. |
artikel |